BNGO
Bionano Delivers Strong Second Quarter 2026 Results: Increased Adoption and Growing Momentum
The company's second quarter 2026 financial results have been announced, showcasing a strong performance driven by increased adoption of its optical genome mapping (OGM) technology. The results reflect a vote of confidence from the routine use customer community and accelerating global adoption of OGM. Speaking on the conference